BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Black LM, Lever JM, Agarwal A. Renal Inflammation and Fibrosis: A Double-edged Sword. J Histochem Cytochem 2019;67:663-81. [PMID: 31116067 DOI: 10.1369/0022155419852932] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Silva JBNF, Calcia TBB, Silva CP, Guilherme RF, Almeida-Souza F, Lemos FS, Calabrese KS, Caruso-Neves C, Neves JS, Benjamim CF. ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice. Int J Mol Sci 2021;22:11634. [PMID: 34769064 DOI: 10.3390/ijms222111634] [Reference Citation Analysis]
2 Ohta S, Asanoma M, Irie N, Tachibana N, Kohno M. Soy Phospholipids Exert a Renoprotective Effect by Inhibiting the Nuclear Factor Kappa B Pathway in Macrophages. Metabolites 2022;12:330. [DOI: 10.3390/metabo12040330] [Reference Citation Analysis]
3 Battistone MA, Mendelsohn AC, Spallanzani RG, Allegretti AS, Liberman RN, Sesma J, Kalim S, Wall SM, Bonventre JV, Lazarowski ER, Brown D, Breton S. Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice. J Clin Invest 2020;130:3734-49. [PMID: 32287042 DOI: 10.1172/JCI134791] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
4 Zhao H, Mei X, Yang D, Tu G. Resveratrol inhibits inflammation after spinal cord injury via SIRT-1/NF-κB signaling pathway. Neurosci Lett 2021;762:136151. [PMID: 34352338 DOI: 10.1016/j.neulet.2021.136151] [Reference Citation Analysis]
5 Ou S, Tsai M, Chen H, Li F, Lee K, Tseng W, Chang F, Lin Y, Yang R, Tarng D. Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression. Biomedicines 2022;10:585. [DOI: 10.3390/biomedicines10030585] [Reference Citation Analysis]
6 Zhao D, Zhu X, Jiang L, Huang X, Zhang Y, Wei X, Zhao X, Du Y. Advances in understanding the role of adiponectin in renal fibrosis. Nephrology (Carlton) 2021;26:197-203. [PMID: 33073881 DOI: 10.1111/nep.13808] [Reference Citation Analysis]
7 Ribeiro A, Dobosz E, Krill M, Köhler P, Wadowska M, Steiger S, Schmaderer C, Koziel J, Lech M. Macrophage-Specific MCPIP1/Regnase-1 Attenuates Kidney Ischemia-Reperfusion Injury by Shaping the Local Inflammatory Response and Tissue Regeneration. Cells 2022;11:397. [PMID: 35159206 DOI: 10.3390/cells11030397] [Reference Citation Analysis]
8 Khunmanee S, Chun SY, Ha YS, Lee JN, Kim BS, Gao WW, Kim IY, Han DK, You S, Kwon TG, Park H. Improvement of IgA Nephropathy and Kidney Regeneration by Functionalized Hyaluronic Acid and Gelatin Hydrogel. Tissue Eng Regen Med 2022. [PMID: 35325404 DOI: 10.1007/s13770-022-00442-8] [Reference Citation Analysis]
9 Li X, Zhuge Z, Carvalho LRR, Braga VA, Lucena RB, Li S, Schiffer TA, Han H, Weitzberg E, Lundberg JO, Carlström M. Inorganic nitrate and nitrite ameliorate kidney fibrosis by restoring lipid metabolism via dual regulation of AMP-activated protein kinase and the AKT-PGC1α pathway. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102266] [Reference Citation Analysis]
10 Das S, Nasim F, Mishra R, Mishra R. Thymic and Peripheral T-cell Polarization in an Experimental Model of Russell's Viper Venom-induced Acute Kidney Injury. Immunol Invest 2021;:1-19. [PMID: 34380374 DOI: 10.1080/08820139.2021.1960369] [Reference Citation Analysis]
11 Nguyen XX, Renaud L, Feghali-Bostwick C. Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5. Int J Mol Sci 2021;22:12609. [PMID: 34830489 DOI: 10.3390/ijms222212609] [Reference Citation Analysis]
12 Formica C, Peters DJM. Molecular pathways involved in injury-repair and ADPKD progression. Cell Signal 2020;72:109648. [PMID: 32320858 DOI: 10.1016/j.cellsig.2020.109648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Laurentius T, Raffetseder U, Fellner C, Kob R, Nourbakhsh M, Floege J, Bertsch T, Bollheimer LC, Ostendorf T. High-fat diet-induced obesity causes an inflammatory microenvironment in the kidneys of aging Long-Evans rats. J Inflamm (Lond) 2019;16:14. [PMID: 31289451 DOI: 10.1186/s12950-019-0219-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hoogenboom LA, Lely AT, Kemp MW, Saito M, Jobe AH, Wolfs TGAM, Schreuder MF. Chorioamnionitis Causes Kidney Inflammation, Podocyte Damage, and Pro-fibrotic Changes in Fetal Lambs. Front Pediatr 2022;10:796702. [DOI: 10.3389/fped.2022.796702] [Reference Citation Analysis]
15 Boumil EF, Castro N, Phillips AT, Chatterton JE, McCauley SM, Wolfson AD, Shmushkovich T, Ridilla M, Bernstein AM. USP10 Targeted Self-Deliverable siRNA to Prevent Scarring in the Cornea. Mol Ther Nucleic Acids 2020;21:1029-43. [PMID: 32829179 DOI: 10.1016/j.omtn.2020.07.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sears S, Siskind L. Potential Therapeutic Targets for Cisplatin-Induced Kidney Injury: Lessons from Other Models of AKI and Fibrosis. J Am Soc Nephrol 2021:ASN. [PMID: 34049962 DOI: 10.1681/ASN.2020101455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kholia S, Herrera Sanchez MB, Cedrino M, Papadimitriou E, Tapparo M, Deregibus MC, Bruno S, Antico F, Brizzi MF, Quesenberry PJ, Camussi G. Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy. Front Cell Dev Biol. 2020;8:188. [PMID: 32266268 DOI: 10.3389/fcell.2020.00188] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
18 Jandl K, Mutgan AC, Eller K, Schaefer L, Kwapiszewska G. The basement membrane in the cross-roads between the lung and kidney. Matrix Biol 2021:S0945-053X(21)00107-4. [PMID: 34839001 DOI: 10.1016/j.matbio.2021.11.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Yang Y, Ha S, Jeong S, Jang CW, Kim J, Im DS, Chung HY, Chung KW. Comparison of two different toxin-induced kidney fibrosis models in terms of inflammatory responses. Toxicology 2021;463:152973. [PMID: 34619300 DOI: 10.1016/j.tox.2021.152973] [Reference Citation Analysis]
20 Rao W, Wang S, Duleba M, Niroula S, Goller K, Xie J, Mahalingam R, Neupane R, Liew AA, Vincent M, Okuda K, O'Neal WK, Boucher RC, Dickey BF, Wechsler ME, Ibrahim O, Engelhardt JF, Mertens TCJ, Wang W, Jyothula SSK, Crum CP, Karmouty-Quintana H, Parekh KR, Metersky ML, McKeon FD, Xian W. Regenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis. Cell 2020;181:848-864.e18. [PMID: 32298651 DOI: 10.1016/j.cell.2020.03.047] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
21 Lo Y, Yang S, Cheng C, Hsu K, Chen Y, Chen Y, Wang C, Guan S, Wu C. Nobiletin Alleviates Ferroptosis-Associated Renal Injury, Inflammation, and Fibrosis in a Unilateral Ureteral Obstruction Mouse Model. Biomedicines 2022;10:595. [DOI: 10.3390/biomedicines10030595] [Reference Citation Analysis]
22 Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular Mechanisms and Therapeutic Targets for Diabetic Kidney Disease. Kidney Int 2022:S0085-2538(22)00436-7. [PMID: 35661785 DOI: 10.1016/j.kint.2022.05.012] [Reference Citation Analysis]
23 Potter JA, Price GW, Cliff CL, Green CR, Squires PE, Hills CE. Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells. Int J Mol Sci 2021;22:3644. [PMID: 33807408 DOI: 10.3390/ijms22073644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yan L, Li YM, Li Y, Bai YJ, Wan ZL, Fan JW, Luo LM, Wang LL, Shi YY. Role of serum CXCL9 and CXCL13 in predicting infection after kidney transplant: A STROBE study. Medicine (Baltimore) 2021;100:e24762. [PMID: 33725942 DOI: 10.1097/MD.0000000000024762] [Reference Citation Analysis]
25 Liu L, Pang X, Shang W, Feng G, Wang Z, Wang J. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway. Ren Fail 2020;42:513-22. [PMID: 32441195 DOI: 10.1080/0886022X.2020.1764854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Liu Q, Li S, Yu L, Yin X, Liu X, Ye J, Lu G. CCL5 Suppresses Klotho Expression via p-STAT3/DNA Methyltransferase1-Mediated Promoter Hypermethylation. Front Physiol 2022;13:856088. [PMID: 35299661 DOI: 10.3389/fphys.2022.856088] [Reference Citation Analysis]
27 Jiang M, Bai M, Xu S, Wang T, Lei J, Xu M, Huang S, Jia Z, Zhang A. Blocking AURKA with MK-5108 attenuates renal fibrosis in chronic kidney disease. Biochim Biophys Acta Mol Basis Dis 2021;1867:166227. [PMID: 34311081 DOI: 10.1016/j.bbadis.2021.166227] [Reference Citation Analysis]
28 Wang R, Hu B, Ye C, Zhang Z, Yin M, Cao Q, Ba Y, Liu H. Stewed Rhubarb Decoction Ameliorates Adenine-Induced Chronic Renal Failure in Mice by Regulating Gut Microbiota Dysbiosis. Front Pharmacol 2022;13:842720. [PMID: 35392552 DOI: 10.3389/fphar.2022.842720] [Reference Citation Analysis]
29 Makitani K, Ogo N, Asai A. STX-0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression. Physiol Rep 2020;8:e14627. [PMID: 33112058 DOI: 10.14814/phy2.14627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Baranwal G, Creed HA, Black LM, Auger A, Quach AM, Vegiraju R, Eckenrode HE, Agarwal A, Rutkowski JM. Expanded renal lymphatics improve recovery following kidney injury. Physiol Rep 2021;9:e15094. [PMID: 34806312 DOI: 10.14814/phy2.15094] [Reference Citation Analysis]
31 Li XQ, Lerman LO, Meng Y. Potential role of extracellular vesicles in the pathophysiology of glomerular diseases. Clin Sci (Lond) 2020;134:2741-54. [PMID: 33111949 DOI: 10.1042/CS20200766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Suo C, Gui Z, Wang Z, Zhou J, Zheng M, Chen H, Fei S, Gu M, Tan R. Bortezomib limits renal allograft interstitial fibrosis by inhibiting NF-κB/TNF-α/Akt/mTOR/P70S6K/Smurf2 pathway via IκBα protein stabilization. Clin Sci (Lond) 2021;135:53-69. [PMID: 33289516 DOI: 10.1042/CS20201038] [Reference Citation Analysis]
33 Zhou J, Li R, Liu Q, Zhang J, Huang H, Huang C, Zhang G, Zhao Y, Wu T, Tang Q, Huang Y, Zhang Z, Li Y, He J. Blocking 5-LO pathway alleviates renal fibrosis by inhibiting the epithelial-mesenchymal transition. Biomed Pharmacother 2021;138:111470. [PMID: 33721755 DOI: 10.1016/j.biopha.2021.111470] [Reference Citation Analysis]
34 Devocelle A, Lecru L, Ferlicot S, Bessede T, Candelier JJ, Giron-Michel J, François H. IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease? Int J Mol Sci 2021;22:11698. [PMID: 34769128 DOI: 10.3390/ijms222111698] [Reference Citation Analysis]
35 Chen F, Gao Q, Wei A, Chen X, Shi Y, Wang H, Cao W. Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis. Cell Death Differ 2021;28:1001-12. [PMID: 33024274 DOI: 10.1038/s41418-020-00631-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
36 Sun W, Byon CH, Kim DH, Choi HI, Park JS, Joo SY, Kim IJ, Jung I, Bae EH, Ma SK, Kim SW. Renoprotective Effects of Maslinic Acid on Experimental Renal Fibrosis in Unilateral Ureteral Obstruction Model via Targeting MyD88. Front Pharmacol 2021;12:708575. [PMID: 34588982 DOI: 10.3389/fphar.2021.708575] [Reference Citation Analysis]
37 Morevati M, Egstrand S, Nordholm A, Mace ML, Andersen CB, Salmani R, Olgaard K, Lewin E. Effect of NAD+ boosting on kidney ischemia-reperfusion injury. PLoS One 2021;16:e0252554. [PMID: 34061900 DOI: 10.1371/journal.pone.0252554] [Reference Citation Analysis]
38 Susilo RJK, Winarni D, Hayaza S, Doong R, Wahyuningsih SPA, Darmanto W. Effect of crude Ganoderma applanatum polysaccharides as a renoprotective agent against carbon tetrachloride-induced early kidney fibrosis in mice. Vet World. [DOI: 10.14202/vetworld.2022.1022-1030] [Reference Citation Analysis]
39 Higgins CE, Tang J, Higgins SP, Gifford CC, Mian BM, Jones DM, Zhang W, Costello A, Conti DJ, Samarakoon R, Higgins PJ. The Genomic Response to TGF-β1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney. Front Cell Dev Biol 2021;9:678524. [PMID: 34277620 DOI: 10.3389/fcell.2021.678524] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Delgado-Valero B, Cachofeiro V, Martínez-Martínez E. Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved. Cells 2021;10:1824. [PMID: 34359993 DOI: 10.3390/cells10071824] [Reference Citation Analysis]
41 Guo W, Chen S, Li C, Xu J, Wang L. Application of Disulfiram and its Metabolites in Treatment of Inflammatory Disorders. Front Pharmacol 2021;12:795078. [PMID: 35185542 DOI: 10.3389/fphar.2021.795078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Liu P, Zhang Z, Li Y. Relevance of the Pyroptosis-Related Inflammasome Pathway in the Pathogenesis of Diabetic Kidney Disease. Front Immunol 2021;12:603416. [PMID: 33692782 DOI: 10.3389/fimmu.2021.603416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ming Y, Cheng S, Long W, Wang HL, Xu C, Liu X, Zhang Q, Zhao S, Zou X, Fan J, Wang L, Shen H. The Herbal Formula Granule Prescription Mahuang Decoction Ameliorated Chronic Kidney Disease Which Was Associated with Restoration of Dysbiosis of Intestinal Microbiota in Rats. Evid Based Complement Alternat Med 2021;2021:4602612. [PMID: 34257680 DOI: 10.1155/2021/4602612] [Reference Citation Analysis]
44 Wang X, Deng J, Xiong C, Chen H, Zhou Q, Xia Y, Shao X, Zou H. Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model. Drug Des Devel Ther 2020;14:2221-33. [PMID: 32606592 DOI: 10.2147/DDDT.S247091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]